Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|January 24, 2009
Benzopyridooxathiazepine derivatives as novel potent antimitotic agentsSebastien Gallet, Nathalie Flouquet, Pascal Carato, et al.European Journal of Medicinal Chemistry|January 29, 2017
New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluationElodie Landagaray, Mohamed Ettaoussi, Marouan Rami, et al.European Journal of Medicinal Chemistry|January 29, 2016
Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivativesElodie Landagaray, Mohamed Ettaoussi, Romain Duroux, et al.European Journal of Medicinal Chemistry|December 22, 2014
Synthesis and pharmacological evaluation of dual ligands for melatonin (MT1/MT2) and serotonin 5-HT2C receptor subtypes (II)Mohamed Ettaoussi, Basile Pérès, Aïcha Errazani, et al.European Journal of Medicinal Chemistry|April 1, 2016
Synthesis of triazoloquinazolinone based compounds as tubulin polymerization inhibitors and vascular disrupting agentsMohsine Driowya, Julien Leclercq, Valerie Verones, et al.Journal of Medicinal Chemistry|November 11, 2005
Novel benzopyridothiadiazepines as potential active antitumor agentsNicolas Lebegue, Sebastien Gallet, Nathalie Flouquet, et al.European Journal of Medicinal Chemistry|April 19, 2011
Antioxydant activity of β-carboline derivatives in the LDL oxidation modelFariza Hadjaz, Soizic Besret, Françoise Martin-Nizard, et al.Chemmedchem|September 14, 2013
Synthesis and pharmacological evaluation of a series of the agomelatine analogues as melatonin MT1 /MT2 agonist and 5-HT2C antagonistMohamed Ettaoussi, Ahmed Sabaouni, Basile Pérès, et al.European Journal of Medicinal Chemistry|February 4, 2012
Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I)Mohamed Ettaoussi, Ahmed Sabaouni, Marouan Rami, et al.European Journal of Medicinal Chemistry|March 8, 2011
Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3Véronique Leclerc, Mohamed Ettaoussi, Marouan Rami, et al.Pageof 4